SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-23-065088
Filing Date
2023-08-09
Accepted
2023-08-09 17:00:37
Documents
14
Period of Report
2022-08-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea183183-8ka_abvcbio.htm   iXBRL 8-K/A 26250
2 ABVC BIOPHARMA, INC. PRESS RELEASE DATED AUGUST 10, 2023 ea183183ex99-1_abvcbiopharm.htm EX-99.1 9158
3 GRAPHIC image_001.jpg GRAPHIC 2254
  Complete submission text file 0001213900-23-065088.txt   216961

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abvc-20220822.xsd EX-101.SCH 2974
5 XBRL LABEL FILE abvc-20220822_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE abvc-20220822_pre.xml EX-101.PRE 22369
8 EXTRACTED XBRL INSTANCE DOCUMENT ea183183-8ka_abvcbio_htm.xml XML 3703
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40700 | Film No.: 231156078
SIC: 2834 Pharmaceutical Preparations